Loading patent…
AssigneeOy Juvantia Pharma Ltd.
InventorsSiegfried Wurster, Mia Engstrom, Liisa Huovinen, Sari Kalliokoski, Leila Kelanne, Eeva-Liisa Savola
Estimating the term…
The present invention relates to a method for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor in a mammal. Said method comprises administering to said mammal an effective amount of a selective alpha-2B-adrenoceptor antagonist, wherein said antagonist is a compound selected from the group consisting of compounds A, B, C, D and E disclosed in Scheme I, or a pharmaceutically acceptable salt of said compound.
A method for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor in a mammal, said method comprising administering to said mammal an effective amount of a selective alpha-2B-adrenoceptor antagonist, wherein said antagonist is a compound selected from the group consisting of compounds A, B, C, D and E disclosed in Scheme I, or a pharmaceutically acceptable salt of said compound.
Dependencies are inferred from the claim text.